Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.

Bart J KramersIris W KoorevaarMaatje D A van GastelHarry van GoorKenneth R Hallows Hiddo J Lambers HeerspinkHui LiWouter N LeonhardDorien J M PetersJiedong QiuDaan J TouwRon T GansevoortEsther Meijer

Published in: Clinical journal of the American Society of Nephrology : CJASN (2022)

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_03_21_CJN11260821.mp3.

Keyphrases

phase iii
open label
phase ii
study protocol
social media
clinical trial
placebo controlled
double blind
health information
polycystic kidney disease
randomized controlled trial